Valuation: Bio-Techne Corporation

Capitalization 7.82B 6.78B 6.36B 5.79B 10.74B 677B 12.15B 75.33B 28.97B 311B 29.35B 28.72B 1,145B P/E ratio 2025 *
49.7x
P/E ratio 2026 * 36x
Enterprise value 7.96B 6.9B 6.47B 5.9B 10.94B 690B 12.37B 76.72B 29.5B 316B 29.88B 29.25B 1,166B EV / Sales 2025 *
6.53x
EV / Sales 2026 * 5.86x
Free-Float
99.46%
Yield 2025 *
0.65%
Yield 2026 * 0.68%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.18%
1 week-2.41%
Current month+1.86%
1 month+4.18%
3 months-18.66%
6 months-32.62%
Current year-31.56%
More quotes
1 week 48.41
Extreme 48.41
51.24
1 month 47.23
Extreme 47.23
52.82
Current year 46.01
Extreme 46.01
79.28
1 year 46.01
Extreme 46.01
83.62
3 years 46.01
Extreme 46.01
99.34
5 years 46.01
Extreme 46.01
135.96
10 years 19.99
Extreme 19.9875
135.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 2024-01-31
Director of Finance/CFO 54 2014-03-31
Investor Relations Contact - 2019-09-30
Director TitleAgeSince
Chairman 69 2012-11-01
Director/Board Member 55 2009-05-18
Director/Board Member 62 2017-10-25
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.18%-2.41%-33.07%-40.19% 7.82B
+0.14%-1.37%+17.56%+13.95% 48.43B
+4.22%-4.50%+64.95%+65.41% 29.32B
+0.28%-1.10%-28.25%-23.08% 26.77B
-1.97%-1.12%-1.96%+15.75% 26.16B
-37.65%+51.34%+22,407.12%+2,669.34% 18.8B
+0.03%-1.33%+12.86%-18.91% 12.32B
-3.89%-7.90%+129.22% - 11.83B
+0.56%+1.13%-53.79%-28.47% 11.64B
-0.63%+2.92%+37.49%+105.04% 10.68B
Average -3.94%+12.71%+2,255.21%+306.54% 20.38B
Weighted average by Cap. -3.26%+11.05%+2,082.42%+275.11%
See all sector performances

Financials

2025 *2026 *
Net sales 1.22B 1.06B 992M 904M 1.68B 106B 1.9B 11.75B 4.52B 48.48B 4.58B 4.48B 179B 1.3B 1.12B 1.05B 960M 1.78B 112B 2.01B 12.49B 4.8B 51.51B 4.87B 4.76B 190B
Net income 166M 144M 135M 123M 227M 14.34B 257M 1.6B 614M 6.58B 622M 608M 24.25B 240M 208M 195M 178M 329M 20.76B 372M 2.31B 888M 9.52B 899M 880M 35.09B
Net Debt 143M 124M 116M 106M 197M 12.41B 223M 1.38B 531M 5.69B 538M 526M 20.98B -228M -197M -185M -169M -313M -19.72B -354M -2.19B -844M -9.05B -855M -837M -33.34B
More financial data * Estimated data
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.4%). Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).
Employees
3,100
More about the company
Date Price Change Volume
25-06-23 49.30 $ -1.18% 1,375,010
25-06-20 49.89 $ -0.48% 2,577,393
25-06-18 50.13 $ +1.27% 2,164,765
25-06-17 49.50 $ -4.13% 2,335,070
25-06-16 51.63 $ +2.20% 1,635,489

Delayed Quote Nasdaq, June 23, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
49.89USD
Average target price
68.95USD
Spread / Average Target
+38.20%
Consensus

Quarterly revenue - Rate of surprise